Pacific Biosciences of California, Inc. operates within the Biotech and Pharmaceuticals industry, focusing on clinical laboratory services and medical devices. The company employs approximately 575 individuals and reported revenue of $154 million. Its expertise is primarily in advanced sequencing technologies, which are pivotal for various applications in genomics. Notably, Pacific Biosciences has collaborated on projects related to wastewater surveillance, particularly in the context of public health. This collaboration highlights the use of culture-independent sequencing methods for pathogen detection, antimicrobial resistance monitoring, and functional analysis in wastewater systems, which have gained prominence due to the COVID-19 pandemic. The company’s published documents include a case study detailing an integrated approach to wastewater surveillance and a checklist for generating hybrid capture libraries for sequencing on its Onso system. These contributions reflect Pacific Biosciences' commitment to advancing genomic technologies and their applications in healthcare and environmental monitoring.